145 related articles for article (PubMed ID: 35440479)
1. Amino Acid PET Imaging with
Djekidel M; Alsadi R; Bouhali O; Maaz AUR
J Nucl Med Technol; 2022 Apr; ():. PubMed ID: 35440479
[TBL] [Abstract][Full Text] [Related]
2. Clinical application of
Masselli G; Casciani E; De Angelis C; Sollaku S; Gualdi G
Am J Nucl Med Mol Imaging; 2021; 11(2):64-76. PubMed ID: 34079636
[TBL] [Abstract][Full Text] [Related]
3.
Humbert O; Bourg V; Mondot L; Gal J; Bondiau PY; Fontaine D; Saada-Bouzid E; Paquet M; Chardin D; Almairac F; Vandenbos F; Darcourt J
Eur J Nucl Med Mol Imaging; 2019 Mar; 46(3):558-568. PubMed ID: 30612162
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Value of 18F-3,4-dihydroxyphenylalanine PET/MR image fusion in pediatric supratentorial infiltrative astrocytomas: a prospective pilot study.
Morana G; Piccardo A; Milanaccio C; Puntoni M; Nozza P; Cama A; Zefiro D; Cabria M; Rossi A; Garrè ML
J Nucl Med; 2014 May; 55(5):718-23. PubMed ID: 24652828
[TBL] [Abstract][Full Text] [Related]
6. Nuclear Medicine in Pediatric and Adolescent Tumors.
Kiratli PÖ; Tuncel M; Bar-Sever Z
Semin Nucl Med; 2016 Jul; 46(4):308-23. PubMed ID: 27237441
[TBL] [Abstract][Full Text] [Related]
7. Dosimetric impact of amino acid positron emission tomography imaging for target delineation in radiation treatment planning for high-grade gliomas.
Kazda T; Pafundi DH; Kraling A; Bradley T; Lowe VJ; Brinkmann DH; Laack NN
Phys Imaging Radiat Oncol; 2018 Apr; 6():94-100. PubMed ID: 33458396
[TBL] [Abstract][Full Text] [Related]
8. Biopsy validation of 18F-DOPA PET and biodistribution in gliomas for neurosurgical planning and radiotherapy target delineation: results of a prospective pilot study.
Pafundi DH; Laack NN; Youland RS; Parney IF; Lowe VJ; Giannini C; Kemp BJ; Grams MP; Morris JM; Hoover JM; Hu LS; Sarkaria JN; Brinkmann DH
Neuro Oncol; 2013 Aug; 15(8):1058-67. PubMed ID: 23460322
[TBL] [Abstract][Full Text] [Related]
9. Early Postoperative
Marner L; Nysom K; Sehested A; Borgwardt L; Mathiasen R; Henriksen OM; Lundemann M; Munck Af Rosenschöld P; Thomsen C; Bøgeskov L; Skjøth-Rasmussen J; Juhler M; Kruse A; Broholm H; Scheie D; Lauritsen T; Forman JL; Wehner PS; Højgaard L; Law I
J Nucl Med; 2019 Aug; 60(8):1053-1058. PubMed ID: 30683767
[TBL] [Abstract][Full Text] [Related]
10. Current status of 18F-DOPA PET imaging in the detection of brain tumor recurrence.
Calabria F; Cascini GL
Hell J Nucl Med; 2015; 18(2):152-6. PubMed ID: 26187216
[TBL] [Abstract][Full Text] [Related]
11. Long-term metabolic evolution of brain metastases with suspected radiation necrosis following stereotactic radiosurgery: longitudinal assessment by F-DOPA PET.
Cicone F; Carideo L; Scaringi C; Romano A; Mamede M; Papa A; Tofani A; Cascini GL; Bozzao A; Scopinaro F; Minniti G
Neuro Oncol; 2021 Jun; 23(6):1024-1034. PubMed ID: 33095884
[TBL] [Abstract][Full Text] [Related]
12. The added diagnostic value of complementary gadoxetic acid-enhanced MRI to
Puhr-Westerheide D; Cyran CC; Sargsyan-Bergmann J; Todica A; Gildehaus FJ; Kunz WG; Stahl R; Spitzweg C; Ricke J; Kazmierczak PM
Cancer Imaging; 2019 Nov; 19(1):73. PubMed ID: 31727170
[TBL] [Abstract][Full Text] [Related]
13. The Utility of Conventional Amino Acid PET Radiotracers in the Evaluation of Glioma Recurrence also in Comparison with MRI.
Santo G; Laudicella R; Linguanti F; Nappi AG; Abenavoli E; Vergura V; Rubini G; Sciagrà R; Arnone G; Schillaci O; Minutoli F; Baldari S; Quartuccio N; Bisdas S
Diagnostics (Basel); 2022 Mar; 12(4):. PubMed ID: 35453892
[TBL] [Abstract][Full Text] [Related]
14. Imaging Findings of
Filippi L; Spanu A; Bagni O; Schillaci O; Palumbo B
Nucl Med Mol Imaging; 2022 Oct; 56(5):245-251. PubMed ID: 36310833
[TBL] [Abstract][Full Text] [Related]
15. Joint EANM/SIOPE/RAPNO practice guidelines/SNMMI procedure standards for imaging of paediatric gliomas using PET with radiolabelled amino acids and [
Piccardo A; Albert NL; Borgwardt L; Fahey FH; Hargrave D; Galldiks N; Jehanno N; Kurch L; Law I; Lim R; Lopci E; Marner L; Morana G; Young Poussaint T; Seghers VJ; Shulkin BL; Warren KE; Traub-Weidinger T; Zucchetta P
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3852-3869. PubMed ID: 35536420
[TBL] [Abstract][Full Text] [Related]
16. Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.
Morana G; Piccardo A; Tortora D; Puntoni M; Severino M; Nozza P; Ravegnani M; Consales A; Mascelli S; Raso A; Cabria M; Verrico A; Milanaccio C; Rossi A
Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):2084-2093. PubMed ID: 28752225
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the amino acid tracers 18F-FET and 18F-DOPA in high-grade glioma patients.
Lapa C; Linsenmann T; Monoranu CM; Samnick S; Buck AK; Bluemel C; Czernin J; Kessler AF; Homola GA; Ernestus RI; Löhr M; Herrmann K
J Nucl Med; 2014 Oct; 55(10):1611-6. PubMed ID: 25125481
[TBL] [Abstract][Full Text] [Related]
18. [F-DOPA PET/MR based target definiton in the 3D based radiotherapy treatment of glioblastoma multiforme patients. First Hungarian experiences].
Sipos D; Tóth Z; Lukács G; Bajzik G; Hadjiev J; Cselik Z; Repa I; Kovács Á
Ideggyogy Sz; 2019 May; 72(5-6):209-215. PubMed ID: 31241266
[TBL] [Abstract][Full Text] [Related]
19. What effective technique to differentiate radiation brain necrosis from a tumor progression in patients treated with radiation: A monocentric retrospective study combining the MRI TRAMs technique and the (
Lakehayli Z; Phlips P; Margoum A; Saoudi A; Hmaid L; Nejjar I; Oueslati H; Bourgois N; Dao S; Belkhir F
Cancer Radiother; 2023 Jun; 27(4):273-280. PubMed ID: 37080856
[TBL] [Abstract][Full Text] [Related]
20. 18F-DOPA PET/CT in the evaluation of hereditary SDH-deficiency paraganglioma-pheochromocytoma syndromes.
Marzola MC; Chondrogiannis S; Grassetto G; Rampin L; Maffione AM; Ferretti A; Opocher G; Schiavi F; Colletti PM; Rubello D
Clin Nucl Med; 2014 Jan; 39(1):e53-8. PubMed ID: 23856824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
